Minimal diversity of drug-resistant Mycobacterium tuberculosis strains, South Africa

Emerg Infect Dis. 2014 Mar;20(3):426-33. doi: 10.3201/eid2003.131083.

Abstract

Multidrug- (MDR) and extensively drug-resistant tuberculosis (XDR TB) are commonly associated with Beijing strains. However, in KwaZulu-Natal, South Africa, which has among the highest incidence and mortality for MDR and XDR TB, data suggest that non-Beijing strains are driving the epidemic. We conducted a retrospective study to characterize the strain prevalence among drug-susceptible, MDR, and XDR TB cases and determine associations between strain type and survival. Among 297 isolates from 2005-2006, 49 spoligotype patterns were found. Predominant strains were Beijing (ST1) among drug-susceptible isolates (27%), S/Quebec (ST34) in MDR TB (34%) and LAM4/KZN (ST60) in XDR TB (89%). More than 90% of patients were HIV co-infected. MDR TB and XDR TB were independently associated with mortality, but TB strain type was not. We conclude that, although Beijing strain was common among drug-susceptible TB, other strains predominated among MDR TB and XDR TB cases. Drug-resistance was a stronger predictor of survival than strain type.

Keywords: HIV; Mycobacterium tuberculosis; South Africa; antimicrobial resistance; bacteria; drug resistance; genotype; transmission; tuberculosis; tuberculosis and other mycobacteria.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antitubercular Agents / pharmacology
  • Coinfection
  • Female
  • Genetic Variation
  • Genotyping Techniques
  • HIV Infections
  • Humans
  • Incidence
  • Male
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis / classification*
  • Mycobacterium tuberculosis / drug effects
  • Mycobacterium tuberculosis / isolation & purification
  • Retrospective Studies
  • South Africa / epidemiology
  • Survival Analysis
  • Tuberculosis, Multidrug-Resistant / epidemiology*
  • Tuberculosis, Multidrug-Resistant / microbiology*

Substances

  • Antitubercular Agents